A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.

Clinical pharmacology in drug development2021Thai C, Tayo B, Critchley D

Study designOther primary literature

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdultAnticonvulsantsCaffeineCannabidiolCentral Nervous System StimulantsCytochrome P-450 CYP1A2Cytochrome P-450 CYP1A2 InhibitorsDrug InteractionsFemaleHumansMaleTheophyllineYoung Adult

DOI 10.1002/cpdd.950

PMID 33951339

View source →